There is no established evidence that semaglutide triggers Crohn's flares, but its gastrointestinal side effects (nausea, diarrhea, abdominal pain) can overlap with and potentially mask disease symptoms
ACS Nano 9, 1058 (2015).CrossRefGoogle ScholarPubMed Nakamura, M., Hayashi, K., Kubo, H., Kanadani, T., Harada, M., and Yogo, T.: Relaxometric property of organosilica nanoparticles internally functionalized with iron oxide and fluorescent dye for multimodal imaging
The result is a terminal elimination half-life of 165168 hours (approximately 7 days), enabling the once-weekly dosing schedule that defines semaglutide's clinical utility
The adverse effects of DPP4is and other antidiabetic drugs are summarized in Table 4 below
Frontiers in Neuroendocrinology
The Eshak cohort study suggests GLP-1 medications may have additional benefits for fibromyalgia symptoms beyond weight loss, but the study has important limitations, and randomised trials specifically in fibromyalgia havent been done